Searches , social queries for MARAVIROC
Search references for MARAVIROC. Phrases containing MARAVIROC
See searches and references containing MARAVIROC!
Search references for MARAVIROC. Phrases containing MARAVIROC
See searches and references containing MARAVIROC!MARAVIROC
Antiretroviral drug
Maraviroc, sold under the brand names Selzentry (US) and Celsentri (EU), is an antiretroviral medication used to treat HIV infection. It is taken by mouth
Maraviroc
Cell entry inhibitor
and Pfizer with maraviroc.[citation needed] All of the compounds reached clinical trials in humans;[citation needed] only maraviroc has been approved[vague]
CCR5_receptor_antagonist
Immune system protein
accommodating both endogenous chemokines and small molecule inhibitors like maraviroc, with key residues such as Glu283 and Tyr251 mediating ligand interactions
CCR5
creating new blood vessels in the body. Another discovery made using HTS is Maraviroc. It is an HIV entry inhibitor, and slows the process and prevents HIV
High_throughput_biology
blocking one of several targets. Maraviroc, enfuvirtide and Ibalizumab are available agents in this class. Maraviroc works by targeting CCR5, a co-receptor
Management_of_HIV/AIDS
Antiviral drug
Vicriviroc, similar to maraviroc, is currently undergoing clinical trials for FDA approval. Aplaviroc, an agent similar to maraviroc and vicriroc. Clinical
Entry_inhibitor
Brazil's federal drug control statute
Stavudine (d4T) Etravirine Fosamprenavir Indinavir Lamivudine (3TC) Lopinavir Maraviroc Nelfinavir Nevirapine Raltegravir Ritonavir Saquinavir Tenofovir Tipranavir
Brazilian Controlled Drugs and Substances Act
Brazilian_Controlled_Drugs_and_Substances_Act
HIV entry inhibitor discovered in 1986
Roy, A.; Dasarathy, S.; Kordower, J. H.; Pahan, K. (2019). "Low-Dose Maraviroc, an Antiretroviral Drug, Attenuates the Infiltration of T Cells into the
Peptide_T
course of the infection. Alternatively to gene therapy, medication such as maraviroc (MVC) is being used to bind with CCR5 particles, blocking the entry of
Innate_resistance_to_HIV
Medication used to treat a viral infection
develop to HTAs. Commonly used FDA-approved HTAs include maraviroc, and interferon. Maraviroc binds to the CCR5 receptor on the surface of host cells.
Antiviral_drug
Regulation of enzyme activity
targets include the calcium-mimicking cinacalcet and the HIV treatment maraviroc.[citation needed] Allosteric proteins are involved in, and are central
Allosteric_regulation
Town in Kent, England
drugs including Viagra, Pfizer's treatment for erectile dysfunction, Maraviroc, a drug used for treatment of HIV and the horse wormer Strongid P were
Sandwich,_Kent
Pharmaceutical company
Lexiva and Telzir) nelfinavir (brand name Viracept) Entry inhibitors: maraviroc (brand names Selzentry and Celsentri) Antiretroviral fixed-dose combinations
ViiV_Healthcare
Letermovir (Prevymis) Cytomegalovirus (CMV) Lopinavir HIV Loviride HIV Maraviroc HIV entry inhibitor Methisazone Smallpox Molnupiravir COVID-19 Merck &
List_of_antiviral_drugs
Substance that binds to a receptor to change its response to stimuli
negative allosteric modulators (NAM) lower agonist affinity and/or efficacy. Maraviroc is a medicine that modulates CCR5. Fenobam, raseglurant and dipraglurant
Allosteric_modulator
International biotechnology laboratory located in United States
Monogram Biosciences Launches New "Trofile" HIV Co-receptor Tropism Test to Select Patients Eligible to User CCR5 Antagonist Maraviroc (Selzentry) [6] v t e
Monogram_Biosciences
American pharmacologist (born 1981)
than reverse transcriptase inhibition such as the HIV entry inhibitor maraviroc; she found that genetic variants of CYP3A genes could impact its clearance
Namandjé_Bumpus
Mammalian protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
Interleukin_8
donor. Other similar cases are being studied to confirm similar results. Maraviroc, the first available CCR5 receptor antagonist, is approved by the FDA
Timeline_of_HIV/AIDS
Pharmaceutical drug classification
J05AX05 Inosine pranobex J05AX06 Pleconaril J05AX07 Enfuvirtide J05AX09 Maraviroc J05AX10 Maribavir J05AX12 Dolutegravir J05AX13 Umifenovir J05AX17 Enisamium
ATC_code_J05
Welsh physician and scientist (born 1966)
12 important medicines including Zithromax (azithromycin), Selzentry (maraviroc), ciprofloxacin and moxifloxacin. Roblin has chaired the research director’s
David_Roblin_(physician)
Protein-coding gene in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
C-C motif chemokine receptor 8
C-C_motif_chemokine_receptor_8
Monoclonal antibody
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
Leronlimab
Mammalian protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CXCL10
Investigational long COVID drugs
against CD3 [16] LTI-2355 – phagocyte modulator [17] Maraviroc/atorvastatin – combination of maraviroc (antiviral/CCR5 receptor antagonist) and atorvastatin
List of investigational long COVID drugs
List_of_investigational_long_COVID_drugs
Chemical compound
cenicriviroc arms. Discovery and development of CCR5-receptor antagonists Maraviroc Vicriviroc "International Nonproprietary Names for Pharmaceutical Substances
Cenicriviroc
Mammalian protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CXCL6
Chemical compound
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
Conolidine
Cytokine receptor
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
Chemokine_receptor
Protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CXCL16
Protein involved in blood clotting, wound healing and inflammation
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
Platelet_factor_4
Protein-coding gene in the species Homo sapiens
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
XCL1
Mammalian protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CCL21
Antiretroviral vaginal ring
inhibitors (Discovery and development) gp41 (Enfuvirtide (ENF, T-20))◊ CCR5 (Maraviroc (MVC) Vicriviroc†, Cenicriviroc†, Leronlimab†) CD4 (Ibalizumab (IBA),
Dapivirine_Ring
HIV prevention strategy using preventative medication for HIV-negative individuals
evidence that other regimens, like ones based on the antiretroviral agent Maraviroc, could potentially prevent HIV infection. Similarly, researchers are investigating
Pre-exposure prophylaxis for HIV prevention
Pre-exposure_prophylaxis_for_HIV_prevention
Physical interactions and constructions between multiple proteins
inhibitor of the glycoprotein IIb/IIIa, used as a cardiovascular drug Maraviroc, inhibitor of the CCR5-gp120 interaction, used as anti-HIV drug. Venetoclax
Protein–protein_interaction
Mammalian protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CXCL9
Chemical compound
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
Aplaviroc
Regulatory protein found in most eukaryotic tissues
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
Ubiquitin
Glycoprotein exposed on the surface of the HIV virus
can physically block gp120 from binding to a cell. Only one such agent, Maraviroc, which binds the co-receptor CCR5 is currently licensed and in clinical
Envelope_glycoprotein_GP120
Protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
Chemerin
Group of cells allowing a pathogen to infect nearby endothelium
Cycle Group Drug(s) Mechanism of Action References Viral Entry Inhibitors Maraviroc Inmazeb Blocks receptor engagement, endocytosis/macropinocytosis, attachment
Endothelial_cell_tropism
Co-packaged antiretroviral medication
inhibitors (Discovery and development) gp41 (Enfuvirtide (ENF, T-20))◊ CCR5 (Maraviroc (MVC) Vicriviroc†, Cenicriviroc†, Leronlimab†) CD4 (Ibalizumab (IBA),
Cabotegravir/rilpivirine
Monoclonal antibody
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
Mogamulizumab
Protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CXCL14
Protein-coding gene in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CXCR3
Protein-coding gene in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CX3CL1
Protein-coding gene in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
C-C_motif_chemokine_ligand_24
British physician
antiviral that is regularly used for antiviral therapy, to etravirine or maraviroc. After completing her doctorate Walters worked in clinical trials at Chelsea
Laura_Waters
American chemist and structural biologist
Wu (2013) Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex Science 341: 1387-90 H. Wu, C. Wang, K. J. Gregory, G. W. Han
Raymond_C._Stevens
Mammalian protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
C-C_chemokine_receptor_type_6
Protein family
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CXC_chemokine_receptors
American neuroscientist (born 1961)
in memory linking that the Silva lab had discovered in 2016. Indeed, Maraviroc, an FDA approved CCR5 inhibitor, as well as a CCR5 genetic mutation, can
Alcino_J._Silva
Pharmaceutical compound
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
NIBR2130
Mammalian protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CXCL2
Chemical compound
antagonists. Studies into vicriviroc are ongoing, and another CCR5 antagonist, maraviroc, is currently on the market. However, concerns have arisen regarding the
Vicriviroc
Protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CCL2
Chemical compound
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
Plerixafor
Mammalian protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CCL7
Mammalian protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CXCL1
Mammalian protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CXCL13
Protein-coding gene in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CCR3
Mammalian protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CCL14
Mammalian protein found in Homo sapiens
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
Interleukin_8_receptor,_beta
Protein
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
Β-Thromboglobulin
Small cytokines or signaling proteins secreted by cells
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
Chemokine
Protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
Atypical_chemokine_receptor_3
American physician
Felstead S, Dunne MW, van der Ryst E, Mayer H; MOTIVATE Study Teams. Maraviroc for previously treated patients with R5 HIV-1 infection. N Engl J Med
Jeffrey_P._Nadler
Monoclonal antibody
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
Ulocuplumab
Pharmaceutical compound
needed] Compared with other antiretroviral drugs such as Enfuvirtide and Maraviroc, VIR-576's mechanism has allowed it to being effective against resistant
VIR-576
Protein-coding gene in the species Homo sapiens
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
C-C_chemokine_receptor_type_7
Protein-coding gene in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CCR4
Protein family
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CC_chemokine_receptors
study designed to learn more about the safety and acceptability of oral maraviroc in at-risk HIV uninfected men who have sex with men (MSM) and in at-risk
HIV_Prevention_Trials_Network
Protein
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CXCR4
Protein-coding gene in the species Homo sapiens
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
Macrophage migration inhibitory factor
Macrophage_migration_inhibitory_factor
Opioid receptor modulator
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
LIH383
Mammalian protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CCL5
Protein-coding gene in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CXCR5
Protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CX3C motif chemokine receptor 1
CX3C_motif_chemokine_receptor_1
Mammalian protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CCL25
Mammalian protein found in Homo sapiens
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
Stromal_cell-derived_factor_1
Mammalian protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CCL4
Mammalian protein found in mice
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CCL9
Mammalian protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CCL3
Protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
Atypical_chemokine_receptor_2
Mammalian protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CCL22
Mammalian protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CCL20
Mammalian protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CCR2
Mammalian protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CCL11
Mammalian protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CXCL5
Synthetic opioid modulator
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
RTI-5152-12
Protein-coding gene in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CCR9
Cytokine
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CXCL17
Mammalian protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CXCL3
Mammalian protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CCL8
Mammalian protein found in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CCL13
Chemical compound
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
Bertilimumab
7-transmembrane protein
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
Interleukin-8_receptor
Protein-coding gene in humans
CCL14 CCL16 NAMs: Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471 Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19
CMKLR1
travel, tourism, insurance
MARAVIROC
MARAVIROC
MARAVIROC
MARAVIROC
MARAVIROC
MARAVIROC
MARAVIROC
MARAVIROC
MARAVIROC
travel, tourism, insurance